Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative ...

Color vision evolved to support survival and social needs. Today, it influences how we think, feel, and navigate the world, ...

Primates broke this mold. Through gene duplication—specifically of opsin genes that code for light-sensitive proteins in the retina—primates, including humans, regained trichromatic vision ...

More information: Isaac H Rossetto et al, Dynamic Expansions and Retinal Expression of Spectrally Distinct Short-Wavelength Opsin Genes in Sea Snakes, Genome Biology and Evolution (2024).

where he significantly contributed to the translation of multi-characteristic opsin (MCO-010). This pharmaceutical candidate is a gene therapy that uses light-sensitive proteins that aims to restore ...

Biomedical engineers at Duke University have developed a novel imaging system that harnesses the power of artificial ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...

A density gradient of basement membrane laminins modulates retinal pigment epithelium contractility levels by differential ...

Retinal detachment is an emergency situation in which the thin tissue layer in the back of your eye lifts away from its usual position. This requires immediate treatment. When part of the tissue ...